Evaluating the Efficacy of Tumor-targeted Antibody in vivo
At present, cancer immunotherapy has been shown to be the most beneficial treatment for cancer patients. Cancer immunotherapy(also called immuno-oncology) refers to a new type of treatment that stimulates the activities of the immune system to specifically attack tumor cells. In 2013, Science Magazine recognized cancer immunotherapy as a "turning point in cancer treatment". In that year, cancer immunotherpay emerged amongst the top ten scientific breakthroughs. In recent years, cancer immunotherapy, such as immune checkpoint inhibitors, has achieved remarkable clinical results.
Shanghai Model Organisms is dedicated to providing "best-in-class" animal models for the development of immunotherapy and antibody therapeutics.
Repository of Immune-HU models
Since 2014, Shanghai Model Organisms has independently developed more than 200 humanized immune checkpoint mouse models (Immune-Hu models), in which mouse immune checkpoint genes were replaced by their human counterparts. In collaboration with our industry partners, our models have been functionally validated, demonstrating their utilities for the accessment of in vivo efficacy of immuno-oncology therapy.
View a complete list of Research-Ready humanized mouse models
To get more info on our product development pipeline, please contact us at email@example.com.
SMOC’s Annual Progress and Advances in Preclinical immuno-Oncology Research: The workshop is designed as a forum for ideas and opinions exchange on how to decrease the rate of clinical failures in oncology and immuno-oncology.Learn more
After the base is put into operation, SMOC’s capability to provide genetically modified rat/mouse models and technical services including gene function research and drug development will be greatly enhanced.Learn more